170 related articles for article (PubMed ID: 22405184)
1. Exacerbation of Crohn's disease as paradoxical effect of infliximab.
Tursi A; Papa A
J Crohns Colitis; 2012 Apr; 6(3):396. PubMed ID: 22405184
[No Abstract] [Full Text] [Related]
2. A rare case of pericarditis, complication of infliximab treatment for Crohn's disease.
Devasahayam J; Pillai U; Lacasse A
J Crohns Colitis; 2012 Jul; 6(6):730-1. PubMed ID: 22465046
[No Abstract] [Full Text] [Related]
3. [Infliximab-induced pustular psoriasis in a patient with Crohn's disease].
Monteagudo Sánchez B; Cabanillas M; Ortiz-Marin S; Gallego-Ojea JC
Gastroenterol Hepatol; 2009 Mar; 32(3):175-6. PubMed ID: 19233516
[No Abstract] [Full Text] [Related]
4. Occurrence of hepatoxicicty and elevated liver enzymes in a Crohn's disease patient treated with infliximab.
Moum B; Konopski Z; Tufteland KF; Jahnsen J
Inflamm Bowel Dis; 2007 Dec; 13(12):1584-6. PubMed ID: 17663423
[No Abstract] [Full Text] [Related]
5. Palmoplantar pustulosis and acrodermatitis in a patient treated with infliximab for Crohn's sacroiliitis.
Wermuth J; Kind F; Steuerwald M
Clin Gastroenterol Hepatol; 2009 Feb; 7(2):A28. PubMed ID: 19187898
[No Abstract] [Full Text] [Related]
6. Colon cancer after infliximab therapy for Crohn's disease.
Ferreira F; Lopes S; Macedo G
BioDrugs; 2010 Dec; 24 Suppl 1():18-21. PubMed ID: 21175230
[TBL] [Abstract][Full Text] [Related]
7. Infliximab-induced acute hepatitis during Crohn's disease therapy: absence of cross-toxicity with adalimumab.
Haennig A; Bonnet D; Thebault S; Alric L
Gastroenterol Clin Biol; 2010 Sep; 34(8-9):e7-8. PubMed ID: 20189334
[No Abstract] [Full Text] [Related]
8. Symptomatic hypokalemia associated with infliximab in a patient with Crohn's disease.
Karamanolis G; Tzathas C; Triantafyllou K; Tsiamoulos Z; Ladas S
Inflamm Bowel Dis; 2006 Oct; 12(10):1010-1. PubMed ID: 17012977
[No Abstract] [Full Text] [Related]
9. Autoimmune hepatitis during infliximab therapy for Crohn's disease: a case report.
Doyle A; Forbes G; Kontorinis N
J Crohns Colitis; 2011 Jun; 5(3):253-5. PubMed ID: 21575891
[TBL] [Abstract][Full Text] [Related]
10. Short-term study of infliximab treatment for Crohn's disease in China.
Zheng JJ; Zhi P; Wang YM; Zhu F; Gu W; Xing YC; Zhou CL; Shen BW
J Dig Dis; 2011 Apr; 12(2):105-9. PubMed ID: 21401895
[TBL] [Abstract][Full Text] [Related]
11. [A case of psoriasis induced by infliximab treatment for Crohn's disease].
Jwa YJ; Kim NH; Park HJ; Park JS; Bae WK; Kim KA; Lee JS; Moon YS
Korean J Gastroenterol; 2010 Nov; 56(5):324-8. PubMed ID: 21099241
[TBL] [Abstract][Full Text] [Related]
12. [Treatment of Crohn's disease by infliximab. About 20 cases].
Serghini M; Karoui S; Meknini M; Matri S; Kallel L; Fekih M; Boubaker J; Filali A
Tunis Med; 2009 Sep; 87(9):579-82. PubMed ID: 20180377
[TBL] [Abstract][Full Text] [Related]
13. Infliximab and adalimumab-induced psoriasis in Crohn's disease: a paradoxical side effect.
Iborra M; Beltrán B; Bastida G; Aguas M; Nos P
J Crohns Colitis; 2011 Apr; 5(2):157-61. PubMed ID: 21453886
[TBL] [Abstract][Full Text] [Related]
14. Abdominal pain due to cholecystitis as first sign of septic salmonellosis in a patient with Crohn's disease on infliximab.
Kukiolka T; Neurath MF; Mudter J
Inflamm Bowel Dis; 2011 Jun; 17(6):E48-9. PubMed ID: 21472825
[No Abstract] [Full Text] [Related]
15. Sarcoidosis during infliximab therapy for Crohn's disease.
Takahashi H; Kaneta K; Honma M; Ishida-Yamamoto A; Ashida T; Kohgo Y; Ohsaki Y; Iizuka H
J Dermatol; 2010 May; 37(5):471-4. PubMed ID: 20536653
[TBL] [Abstract][Full Text] [Related]
16. Case report of aseptic meningitis in a patient with Crohn's disease under infliximab therapy.
Manthey C; Lohse AW; Pace A
Inflamm Bowel Dis; 2011 Feb; 17(2):E10. PubMed ID: 20848497
[No Abstract] [Full Text] [Related]
17. Long-term durability of infliximab treatment in Crohn's disease and efficacy of dose "escalation" in patients losing response.
Chaparro M; Panes J; García V; Mañosa M; Esteve M; Merino O; Andreu M; Gutierrez A; Gomollón F; Cabriada JL; Montoro MA; Mendoza JL; Nos P; Gisbert JP
J Clin Gastroenterol; 2011 Feb; 45(2):113-8. PubMed ID: 21242747
[TBL] [Abstract][Full Text] [Related]
18. Infliximab and adalimumab-induced thrombocytopenia in a woman with colonic Crohn's disease.
Salar A; Bessa X; Muñiz E; Monfort D; Besses C; Andreu M
Gut; 2007 Aug; 56(8):1169-70. PubMed ID: 17344276
[No Abstract] [Full Text] [Related]
19. Splenic tuberculosis in a patient with Crohn's disease on infliximab: case report.
Cappello M; Randazzo C; Rizzuto G; Bonura C; Di Vita G; Galia M
Inflamm Bowel Dis; 2010 Mar; 16(3):368-70. PubMed ID: 19591134
[No Abstract] [Full Text] [Related]
20. Safety and efficacy of maintenance infliximab therapy for moderate-to-severe Crohn's disease in children: REACH open-label extension.
Hyams J; Walters TD; Crandall W; Kugathasan S; Griffiths A; Blank M; Johanns J; Lang Y; Markowitz J; Cohen S; Winter HS; Veereman-Wauters G; Ferry G; Baldassano R
Curr Med Res Opin; 2011 Mar; 27(3):651-62. PubMed ID: 21241207
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]